Amgen Inc

Stock Chart, Company Information, and Scan Results

$348.43(as of Mar 24, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Amgen Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$348.43
Ticker SymbolAMGN
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees31,500
CountyUSA
Market Cap$188,549.7M
EBIDTA16,617.0M
10-Day Moving Average358.64
P/E Ratio24.54
20-Day Moving Average368.49
Forward P/E Ratio15.85
50-Day Moving Average359.16
Earnings per Share14.24
200-Day Moving Average313.53
Profit Margin13.47%
RSI37.05
Shares Outstanding539.1M
ATR8.55
52-Week High391.29
Volume2,269,542
52-Week Low253.48
Most Recent Support Level344.95
Book Value8,658.0M
Most Recent Resistance Level353.42
P/B Ratio21.85
Upper Keltner387.72
P/S Ratio5.15
Lower Keltner349.25
Debt-to-Equity Ratio387.72
Next Earnings Date04/29/2026
Cash Surplus-16,360.0M
Next Ex-Dividend Date05/15/2026

Amgen is a leader in medicinal breakthroughs as it pioneered ways to use living cells to develop biological medicines. The biotech develops and commercializes drugs to treat conditions like cancer, cardiovascular disease, and bone health. The company’s top-selling drugs, Aranesp and Kyprolis, are used to treat anemia and cancer respectively.

Amgen Inc In Our Stock Scanner

As of Mar 25, 2026
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.